Cantharidin: Clinical Trials

3 trials of Cantharidin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1

Follow Cantharidin: new trials by email Literature Review of Cantharidin trials Research Report on Cantharidin

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699
Placebo, GSK3358699, GM-CSF - Arthritis, Rheumatoid
Phase 1TerminatedGlaxoSmithKline482018-03-132020-12-02
Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects
Cantharidin, Lipopolysaccharide, Granulocyte-Macrophage Colony-Stimulating Factor - Arthritis, Rheumatoid
Phase 1CompletedGlaxoSmithKline122017-08-112019-08-08
Cantharidin-induced Skin Blister for Testing Anti-inflammatory Effects of Macrolides
Cantharidin, Azithromycin, Placebo - Inflammation
Phase 1CompletedGlaxoSmithKline442009-06-042017-07-25

Conditions studied

Arthritis, Rheumatoid (2)  ·  Inflammation (2)  ·  Blister (1)

Sponsors

GlaxoSmithKline (3)

Countries

United Kingdom (3)

Results publications

PMID 23629714, PMID 34773923

NIH funding

2017 (1)